Cover Image

The federal government's investment in new drug research and development : are we getting our money's worth? : hearing before the Special Committee on Aging, United States Senate, One Hundred Third Congress, first session, Washington, DC, February 24, 1993.

Bibliographic Details
Corporate Authors:	United States. Congress. Senate. Special Committee on Aging, ProQuest (Firm)
Format:	Government Document eBook
Language:	English
Published:	Washington : U.S. G.P.O., 1993.
Series:	U.S. Congressional Hearings.
Subjects:	Drugs > Research > United States > Finance. Drugs > Prices > United States. Pharmaceutical industry > United States. Pharmaceutical policy > United States. Electronic books.
Online Access:	Connect to the full text of this electronic book

Similar Items

Prescription drug pricing in the private sector.
Published: (2007)

Pricing of drugs codeveloped by federal laboratories and private companies : hearing before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, first session, Washington, DC, January 25, 1993.
Published: (1993)

Pricing of drugs, 1977 : joint hearing before the Subcommittee on Health and Scientific Research of the Committee on Human Resources and the Subcommittee on Antitrust and Monopoly of the Committee on the Judiciary, United States Senate, 95th Congress, first session ... July 14, 1977.
Published: (1977)

Making medicine, making money /
by: Drake, Donald, 1935-
Published: (1993)

Drug topics red book.
Published: (1992)

Drug product selection : staff report to the Federal Trade Commission.

Studies in pharmaceutical economics /
Published: (1996)

Economic analysis of the causes of drug shortages.
Published: (2011)

Drug shortages : why they happen and what they mean : hearing before the Committee on Finance, United States Senate, One Hundred Twelfth Congress, first session, December 7, 2011.
Published: (2011)

Drug topics red book.
Published: (1995)

Prescription drug shortages : examining a public health concern and potential solutions : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, first session ... December 15, 2011.
Published: (2014)

Earning a failing grade : a report card on 1992 drug manufacturer price inflation : staff report to the Special Committee on Aging, United States Senate.
Published: (1993)

Drug shortage crisis : lives are in the balance : hearing before the Subcommittee on Health Care, District of Columbia, Census, and the National Archives of the Committee on Oversight and Government Reform, House of Representatives, One Hundred Twelfth Congress, first session, November 30, 2011.
Published: (2012)

Entry threats and pricing in the generic drug industry /
by: Wendling, Brett
Published: (2010)

Medicaid drug pricing in state maximum allowable cost programs.
Published: (2013)

Reasonable Rx : solving the drug price crisis /
by: Finkelstein, Stan N.
Published: (2008)

The demand for prescription drugs as a function of cost-sharing /
by: Leibowitz, Arleen A.
Published: (1985)

Competition in prescription drug markets, 2017-2022 /
by: Parasrampuria, Sonal, et al.
Published: (2023)

Pharmaceutical marketplace reform : is competition the right prescription? : hearing before the Special Committee on Aging, United States Senate, One Hundred Third Congress, first session, Washington, DC, November 16, 1993.
Published: (1994)

Red book.
Published: (2004)

Seniors feeling the squeeze : rising drug prices and the Part D program : hearing before the Special Committee on Aging, United States Senate, One Hundred Eleventh Congress, second session, Washington, DC, March 17, 2010.
Published: (2010)

Drug pricing investigation: AbbVie : Humira and Imbruvica : staff report /
Published: (2021)

The truth about the drug companies : how they deceive us and what to do about it /
by: Angell, Marcia
Published: (2004)

Things to think about when you compare Medicare drug coverage.
Published: (2014)

Pharmacy benefit managers : early results on ventures with drug manufacturers : report to the Honorable Ron Wyden, House of Representatives /
Published: (1995)

Drug shortages, public health threat continues, despite efforts to help ensure product availability : report to congressional addressees.
Published: (2014)

A Status report, accessibility and affordability of prescription drugs for older Americans : (includes a directory of pharmaceutical manufacturer indigent patient programs) : a staff report of the Special Committee on Aging, United States Senate.
Published: (1992)

Lower drug costs now : expanding access to affordable health care : hearing before the Subcommittee on Health, Employment, Labor, and Pensions of the Committee on Education and Labor, U.S. House of Representatives, One Hundred Seventeenth Congress, first session, hearing held in Washington, DC, May 5, 2021.
Published: (2022)

Effects of using generic drugs on Medicare's prescription drug spending.
by: Somers, Julie
Published: (2010)

Drug pricing investigation : majority staff report /
Published: (2021)

Short-supply prescription drugs : shining a light on the gray market : hearing before the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Twelfth Congress, second session, July 25, 2012.
Published: (2013)

Effects of medicare's drug pricing on other purchasers.
Published: (2007)

Medicare Part D : Drug Pricing and Manufacturer Windfalls.
Published: (2008)

Prescription drugs : the number, role, and ownership of pharmacy services administrative organizations : report to the Ranking Member, Committee on Energy and Commerce, House of Representatives.
Published: (2013)

Designing a twenty-first century Medicare prescription drug benefit : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, first session, April 8, 2003.
Published: (2003)

Designing a twenty-first century Medicare prescription drug benefit : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, first session, April 8, 2003.
Published: (2003)

Orphan drugs : medical versus market value /
by: Asbury, Carolyn H.
Published: (1985)

The complex web of prescription drug prices : hearing before the Special Committee on Aging, United States Senate, One Hundred Sixteenth Congress, first session, Washington, DC.
Published: (2022)

Competitive Problems in the Drug Industry. hearings before the United States Senate Select Committee on Small Business, Subcommittee on Monopoly, Ninetieth Congress, first session and Ninetieth Congress, second session, on Dec. 14, 19, 1967; Jan. 18, 19, 25, 1968.
Published: (1968)

The generic drug maze : speeding access to affordable life-saving drugs : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, second session, Washington, DC, July 20, 2006.
Published: (2006)